Chinese Firms Build Obesity Clinical Pipeline But Face Wider Hurdles

 
• By Xu Hu
  
Obesity management
Chinese biopharma firms are building their R&D presence in obesity but face multiple challenges in the developing domestic sector. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Therapy Areas